- Page 1 and 2: NUCLEAR / MOLECULAR IMAGING (SCINTI
- Page 3 and 4: NUCLEAR / MOLECULAR IMAGING (SCINTI
- Page 5: NUCLEAR IMAGING (SCINTIGRAPHY) Sing
- Page 9 and 10: HISTORY OF NUCLEAR MEDICINE
- Page 11 and 12: RATIONAL THINKING: Epilepsy: “...
- Page 13 and 14: PHILOSOPHY A philosopher Loves (phi
- Page 15 and 16: The First Philosophers (+Scientists
- Page 17 and 18: The Miracle of the 5th Century BC A
- Page 19 and 20: CLASSICAL CIVILIZATION WAS ALSO TRA
- Page 21 and 22: EPICUROS A PHILOSOPHER OF THE ROMAN
- Page 23 and 24: THERE FOLLOWS RELIGIOUS POWERS Byza
- Page 25 and 26: AND THE MEDIEVAL TIMES CHRISTIANS M
- Page 27 and 28: HISTORY It took more than 2000 year
- Page 29: HISTORY Dmitry Ivanovic Mendeleyev
- Page 32 and 33: HISTORY Theory of Relativity 1905-1
- Page 34 and 35: KING CHARLE’S II in his TUBERCULO
- Page 36 and 37: FINALLY RENAISSANCE CAME TO MEDICIN
- Page 38 and 39: PHYSICS AND INSTRUMENTATION
- Page 40 and 41: RADIOACTIVE ATOM DECAY a) Electroma
- Page 42 and 43: RADIOISOTOPES IN NUCLEAR MEDICINE P
- Page 44 and 45: A. SINGLE PHOTON IMAGING PLANAR and
- Page 46 and 47: HISTORY Rectilinear Scanner 1954 Wi
- Page 48 and 49: ANGER GAMMA CAMERA
- Page 50 and 51: SPECT JASZCZACK PHANTOM STUDIES
- Page 52 and 53: TOMOGRAPHY SINGLE PHOTON (γ,x) TOM
- Page 54 and 55: SPECT HOFFMAN PHANTOM STUDIES
- Page 56 and 57:
SPECT CAMERA THREE DETECTOR
- Page 58 and 59:
Functional Nuclear Studies Sculptur
- Page 60 and 61:
SPECT/CT Combines a Dual-headed Gam
- Page 62 and 63:
111 In Prostascint SPECT / CT Symbi
- Page 64 and 65:
111 In Octreotide SPECT/CT Symbia P
- Page 66 and 67:
Primary (Pancreas) and Metastatic (
- Page 68 and 69:
99m Tc-Sestamibi SPCT/CT Parathyroi
- Page 70 and 71:
B. POSITRON EMISSION TOMOGRAPHY (PE
- Page 72 and 73:
HISTORY Development of PET Scanner
- Page 74 and 75:
CYCLOTRON: STRUCTURE AND FUNCTION E
- Page 76 and 77:
CYCLOTRON:SYNTHESIS OF RADIOPHARMAC
- Page 78 and 79:
POSITRON DECAY: ANNIHILATION OF e +
- Page 80 and 81:
POSITRON EMISSION TOMOGRAPHY (PET)
- Page 82 and 83:
PET CLINICAL APPLICATIONS • Brain
- Page 84 and 85:
WHAT IS FDG-PET AND HOW DOES IT WOR
- Page 86 and 87:
PRINCIPLES OF FDG IMAGING FDG enter
- Page 88 and 89:
CLINICAL EXPERIENCE with FDG/PET TU
- Page 90 and 91:
CLINICAL EXPERIENCE with FDG/PET TU
- Page 92 and 93:
IMAGE FUSION ? ? CT PET CT FUSED WI
- Page 94 and 95:
EQUIPMENT FOR PET and PET/CT SCINTI
- Page 96 and 97:
QUANTIFICATION OF PET STUDIES Accur
- Page 98 and 99:
The EVOLUTION of CLINICAL FDG/PET I
- Page 100 and 101:
NUCLEAR MEDICINE STUDIES Safe Easy
- Page 102 and 103:
RADIATION AND LIFE Nuclear Imaging
- Page 104 and 105:
QUANTITATIVE SCINTIGRAPHY 2 3 ACCUR
- Page 106 and 107:
QUALITY CONTROL IN NM OFF PEAK PEAK
- Page 108 and 109:
NUCLEAR MEDICINE STUDIES AT JMH/UM
- Page 110 and 111:
THERAPY WITH SYSTEMIC USE OF UNSEAL
- Page 112 and 113:
Radiation Safety Issues (environmen
- Page 114 and 115:
GRAVES DISEASE At treatment (15 mCi
- Page 116 and 117:
Nuclear Synovectomy INDICATIONS Hem
- Page 118 and 119:
THERAPY OF TUMORS with UNSEALED or
- Page 120 and 121:
THERAPY OF INTRACTABLE BONE PAIN DU
- Page 122 and 123:
RADIOIMMUNOTHERAPY IN NON-HODGKIN
- Page 124 and 125:
Rituximab: First Monoclonal Antibod
- Page 126 and 127:
Radioimmunotherapy Yttrium 90 ibrit
- Page 128 and 129:
90 Y Ibritumomab Tiuxetan Monoclona
- Page 130 and 131:
Zevalin Integrated Safety (N = 349)
- Page 132:
BOARDS IN NUCLEAR MEDICINE 1) AMERI
Change language